David L. Groteluschen
Expertise in
33
conditions

Dr. David L. Groteluschen

Oncology
1726 Shawano Ave, 
Green Bay, WI 
Accepting New Patients
Expertise in
33
conditions
1726 Shawano Ave, 
Green Bay, WI 

Overview

David L. Groteluschen, MD, is a board-certified, independent medical oncologist at Ascension Wisconsin in Green Bay, WI. Dr. Groteluschen diagnoses and treats blood diseases and blood cancer. Every appointment with Dr. Groteluschen starts with a conversation. He takes the time to answer all your questions - big and small.

Dr. Groteluschen is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, and Bone Marrow Aspiration.

Dr. Groteluschen is board certified in The American Board Of Internal Medicine - Medical Oncology, American Board Of Internal Medicine, and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 6 peer reviewed articles. Dr. Groteluschen is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in WI

Board Certifications

The American Board Of Internal Medicine - Medical Oncology
American Board Of Internal Medicine
The American Board Of Internal Medicine - Internal Medicine

Fellowships

University of Wisconsin-Madison

Hospital Affiliations

Ascension Ne Wisconsin - St Elizabeth Campus
St Marys Hospital Medical Ctr
Door County Medical Center
St Vincent Hospital
Ascension Calumet Hospital
Ascension NE Wisconsin - Mercy Campus
Ascension NE Wisconsin - St. Elizabeth Campus

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Children's Community Health
  • EPO
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Green Bay Oncology, Ltd. - St. Mary Site
1726 Shawano Ave, Green Bay, WI 54303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Total Publications

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).
Journal: Clinical genitourinary cancer
Published: January 05, 2017
Similar Doctors
Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

HSHS St. Mary's Hospital Medical Center

1726 Shawano Ave, 
Green Bay, WI 
 (0.1 miles away)
920-884-3135
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ruth Warren is an Oncologist practicing medicine in Green Bay, Wisconsin. Dr. Warren is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Endoscopy. Dr. Warren is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Hassan Tahsildar, MD

1580 Commanche Ave, 
Green Bay, WI 
 (3.3 miles away)
920-435-8326
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Hassan Tahsildar is an Oncologist practicing medicine in Green Bay, Wisconsin. Dr. Tahsildar is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Small Cell Lung Cancer (SCLC), Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Endoscopy. Dr. Tahsildar is currently accepting new patients.

Expertise in
50
conditions
Dr. Michael P. Mullane
Hematology | Oncology
Expertise in
50
conditions
Dr. Michael P. Mullane
Hematology | Oncology
Referral may be required
Before you request

Aurora BayCare Medical Center

2845 Greenbrier Rd, 
Green Bay, WI 
 (7.4 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Mullane is a Hematologist and an Oncologist practicing medicine in Green Bay, Wisconsin. Dr. Mullane is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Mullane is board certified in American Board Of Internal Medicine, Hematology. Dr. Mullane is currently accepting new patients.

Frequently Asked Questions about Dr. David L. Groteluschen

How do I make an appointment with Dr. David L. Groteluschen?

You can book an appointment with Dr. David L. Groteluschen by calling their office at 920-432-6049. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David L. Groteluschen a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David L. Groteluschen is classified as an Distinguished expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David L. Groteluschen specialize in?

While Dr. David L. Groteluschen is a Oncology, they have specific expertise in Myelodysplastic Syndrome (MDS), Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. David L. Groteluschen participate in research or clinical trials?

Yes. Dr. David L. Groteluschen has published 6 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Dr. David L. Groteluschen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David L. Groteluschen accept my insurance?

Dr. David L. Groteluschen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 920-432-6049 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Groteluschen's expertise for a condition
ConditionClose
    View All 10 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 114 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile